Individual investors who file shareholder proposals have played a significant and consequential role in advancing sound corporate governance. Yet their contribution is often overlooked.
Recent debate over the shareholder proposal process has drawn strong responses from institutional investors, faith-based investors, and pension funds seeking to protect shareholders’ ability to engage companies through proposals. Missing from much of that discussion is the impact of individual investors – particularly John Chevedden and James McRitchie.
Together, Chevedden and McRitchie have filed thousands of proposals asking companies to improve their governance policies and practices. Institutional investors frequently support these reforms, regardless of whether the proposal comes from a prominent institution or an individual shareholder. Some of the practices they championed have become widely accepted; others remain contested. Not every proposed reform is necessarily right for every company, but each deserves thoughtful scrutiny and consideration.
Guest post by Timothy Smith, Senior Policy Advisor, Interfaith Center on Corporate Responsibility. research assistance by Sehr Khaliq, ICCR Director of Evaluation. Originally posted to ICCR on August 21, 2026. EDITORIAL NOTE: The source narrative says 125 proposals received more than 25% support, but the complete source tables contain 123 such entries. This version uses 123 so the prose matches the supplied data. Confirm with ICCR before changing the count. I also bolded the links and created more of them, as well as adding the big attention grabbing graphic and following song. (Both added using AI).
Companies respond to individual proponents in sharply different ways. Some engage constructively and adopt full or partial reforms. Others seek to exclude their proposals through the Securities and Exchange Commission’s no-action process or through litigation.
SEC Chair Paul Atkins recently criticized the concentration of filings by one individual. In a July 2026 speech to the Society for Corporate Governance, he noted that one person was the sole or lead proponent for approximately 41% of shareholder proposals voted on during the season. He treated that concentration, and the fact that only 8% of those proposals won majority support, as evidence that the system needs reform.
That framing misses the larger point. A proposal need not win a majority to identify a governance weakness, attract substantial investor concern, or prompt a board to act. Support from one-quarter, one-third, or nearly one-half of votes cast is consequential. It signals that a significant portion of the company’s investors believes the board should address the issue.
Even skeptics have acknowledged Chevedden’s influence. In a 2013 Reuters special report, James Copland of the Manhattan Institute described him as “leading the intellectual curve, getting proposals out there before they start to get traction.”
For more background, see ICCR’s The Power of Individual Investors to Catalyze Change, McRitchie’s John Chevedden: Economy-Class Investor Advocate, and Three Shareholder Rights Advocates: Gilbert, Chevedden, McRitchie.
In 2026, Chevedden filed more than 200 shareholder proposals. Some were challenged, some did not reach a vote, and others were withdrawn following discussions with management. The data supplied for this article identify 123 proposals that received at least 25% support, including several that won majority support and one that approached 98%.
The proposals covered familiar but important governance subjects: majority voting in director elections, equal voting rights, political-spending disclosure, shareholder rights to call special meetings or act by written consent, independent board leadership, executive equity retention, golden parachutes, and poison pills.
These results rebut the idea that frequent individual proponents merely clutter corporate ballots with idiosyncratic demands. Large numbers of investors repeatedly supported the reforms. The proposal may originate with one person, but the vote reflects the judgment of the broader shareholder base.
The SEC and corporate trade associations have debated whether shareholders should be required to own substantially more stock before submitting a proposal. Texas has gone further. Senate Bill 1057, effective September 1, 2025, permits an eligible publicly traded Texas corporation to opt into a regime under which a proponent must hold at least $1 million in voting shares or 3% of the company’s voting shares, maintain that holding for at least six months through the meeting, and solicit holders representing at least 67% of the voting power entitled to vote on the proposal.
Those requirements would effectively exclude most individual investors. They rest on a mistaken premise: that the value of an idea depends on the wealth of the person advancing it. The history of corporate governance shows otherwise. Individual proponents have repeatedly identified reforms that later gained broad investor support and became accepted practice.
The shareholder proposal process gives investors an orderly, nonbinding mechanism to raise issues and test support across the ownership base. Boards remain free to explain their opposition, and shareholders remain free to vote no. Silencing smaller investors before their ideas can be considered does not protect shareholder democracy; it impoverishes it.
The 2026 voting results below demonstrate the important role individual investors play. That role should be protected, not eradicated.
Source: Data supplied by John Chevedden and cross-checked against ICCR’s database. Vote percentages are reproduced from the source document.
| Resolution | Company | Lead filer | Vote |
|---|---|---|---|
| Annual Board Election | Fortune Brands | John Chevedden | 74.20% |
| Resolution | Company | Lead filer | Vote |
|---|---|---|---|
| Annual Vote Regarding Executive Pay | Meta (Facebook Inc.) | John Chevedden | 27.10% |
| Resolution | Company | Lead filer | Vote |
|---|---|---|---|
| Give Each Share an Equal Vote | Ford Motor Company | John Chevedden | 43.10% |
| Give Each Share an Equal Vote | United Parcel Service (UPS) | John Chevedden | 40.20% |
| Give Each Share an Equal Vote | Lennar Corporation | John Chevedden | 36.70% |
| Resolution | Company | Lead filer | Vote |
|---|---|---|---|
| Majority Vote | BJ’s Wholesale | John Chevedden | 27.40% |
| Majority Vote | Datadog, Inc. | John Chevedden | 42.30% |
| Majority Vote | Henry Schein, Inc. | John Chevedden | 57.60% |
| Majority Vote | Calix | John Chevedden | 90.60% |
| Majority Vote | onsemi (On Semiconductor) | John Chevedden | 97.90% |
| Majority Vote | NVIDIA | John Chevedden | 86.00% |
| Majority Vote | OGE Energy Corporation | John Chevedden | 79.80% |
| Majority Vote | WEC Energy Group Inc. | John Chevedden | 37.30% |
| Majority Vote | Wells Fargo & Company | John Chevedden | 47.90% |
| Resolution | Company | Lead filer | Vote |
|---|---|---|---|
| Political Contributions | Booking Holdings | John Chevedden | 35.00% |
| Political Contributions | Knight-Swift Transportation Holdings Inc. | John Chevedden | 39.40% |
| Political Contributions | Otis Worldwide Corp. | John Chevedden | 39.70% |
| Political Contributions | Akamai Technologies, Inc. | John Chevedden | 45.40% |
| Political Contributions | Steel Dynamics, Inc. | John Chevedden | 39.30% |
| Political Contributions | O’Reilly Automotive, Inc. | John Chevedden | 44.20% |
| Political Contributions | Sonoco Products Company | John Chevedden | 41.50% |
| Resolution | Company | Lead filer | Vote |
|---|---|---|---|
| Require Shareholder Approval for Excessive Golden Parachutes | Humana Inc. | John Chevedden | 41.10% |
| Require Shareholder Approval for Excessive Golden Parachutes | CF Industries Holdings, Inc. | John Chevedden | 50.90% |
| Resolution | Company | Lead filer | Vote |
|---|---|---|---|
| Right of Shareholders to Call Special Meetings | Goldman Sachs Group Inc. | John Chevedden | 36.80% |
| Right of Shareholders to Call Special Meetings | First Solar, Inc. | John Chevedden | 43.00% |
| Right of Shareholders to Call Special Meetings | Meritage Homes Corp. | John Chevedden | 25.50% |
| Right of Shareholders to Call Special Meetings | L3Harris Technologies | John Chevedden | 33.20% |
| Right of Shareholders to Call Special Meetings | IDEXX Laboratories, Inc. | John Chevedden | 41.20% |
| Right of Shareholders to Call Special Meetings | MarketAxess Holdings Inc. | John Chevedden | 28.40% |
| Right of Shareholders to Call Special Meetings | PayPal | John Chevedden | 41.10% |
| Right of Shareholders to Call Special Meetings | CBRE Group, Inc. | John Chevedden | 33.90% |
| Right of Shareholders to Call Special Meetings | Equinix, Inc. | John Chevedden | 30.20% |
| Right of Shareholders to Call Special Meetings | HubSpot, Inc. | John Chevedden | 79.20% |
| Right of Shareholders to Call Special Meetings | Autodesk Inc. | John Chevedden | 47.50% |
| Right of Shareholders to Call Special Meetings | Markel Corporation | John Chevedden | 37.30% |
| Right of Shareholders to Call Special Meetings | AGCO Corporation | John Chevedden | 48.60% |
| Right of Shareholders to Call Special Meetings | MKS Instruments | John Chevedden | 32.60% |
| Right of Shareholders to Call Special Meetings | Medpace Holdings | John Chevedden | 34.10% |
| Right of Shareholders to Call Special Meetings | Masco Corporation | John Chevedden | 42.60% |
| Right of Shareholders to Call Special Meetings | Group 1 Automotive, Inc. | John Chevedden | 25.30% |
| Right of Shareholders to Call Special Meetings | EPAM Systems, Inc. | John Chevedden | 43.40% |
| Right of Shareholders to Call Special Meetings | Timken Company | John Chevedden | 41.40% |
| Right of Shareholders to Call Special Meetings | Graphic Packaging Holdings | John Chevedden | 42.10% |
| Right of Shareholders to Call Special Meetings | Arrow Electronics | John Chevedden | 37.00% |
| Right of Shareholders to Call Special Meetings | Regions Financial Corporation | John Chevedden | 43.70% |
| Right of Shareholders to Call Special Meetings | Boston Scientific Corporation | John Chevedden | 42.60% |
| Right of Shareholders to Call Special Meetings | S&P Global | John Chevedden | 40.80% |
| Right of Shareholders to Call Special Meetings | AES Corporation | John Chevedden | 34.70% |
| Right of Shareholders to Call Special Meetings | ICU Medical | John Chevedden | 40.70% |
| Right of Shareholders to Call Special Meetings | Eastman Chemical Company | John Chevedden | 27.80% |
| Right of Shareholders to Call Special Meetings | Equifax Inc. | John Chevedden | 36.30% |
| Right of Shareholders to Call Special Meetings | Entegris Inc. | John Chevedden | 31.20% |
| Right of Shareholders to Call Special Meetings | Cincinnati Financial Corp. | John Chevedden | 27.20% |
| Right of Shareholders to Call Special Meetings | Albemarle Corporation | John Chevedden | 57.50% |
| Right of Shareholders to Call Special Meetings | Advanced Micro Devices, Inc. | John Chevedden | 37.40% |
| Right of Shareholders to Call Special Meetings | Ally Financial | John Chevedden | 29.40% |
| Right of Shareholders to Call Special Meetings | Murphy Oil Company | John Chevedden | 33.90% |
| Right of Shareholders to Call Special Meetings | NRG Energy, Inc. | John Chevedden | 55.50% |
| Right of Shareholders to Call Special Meetings | NVR, Inc. | John Chevedden | 47.10% |
| Right of Shareholders to Call Special Meetings | Sherwin-Williams Company | John Chevedden | 43.30% |
| Right of Shareholders to Call Special Meetings | TransUnion | John Chevedden | 72.00% |
| Right of Shareholders to Call Special Meetings | Qualcomm Inc. | John Chevedden | 42.10% |
| Right of Shareholders to Call Special Meetings | Keysight Technologies | John Chevedden | 65.00% |
| Right of Shareholders to Call Special Meetings | Micron Technology, Inc. | John Chevedden | 42.90% |
| Resolution | Company | Lead filer | Vote |
|---|---|---|---|
| Right To Act By Written Consent | Netflix, Inc. | John Chevedden | 44.40% |
| Right To Act By Written Consent | Caterpillar Inc. | John Chevedden | 39.20% |
| Right To Act By Written Consent | Delta Air Lines, Inc. | John Chevedden | 31.10% |
| Right To Act By Written Consent | Cognizant Technology Solutions Corp. | John Chevedden | 39.00% |
| Right To Act By Written Consent | United Airlines Holdings, Inc. | John Chevedden | 38.50% |
| Right To Act By Written Consent | AT&T Inc. | John Chevedden | 32.00% |
| Right To Act By Written Consent | Zoetis, Inc. | John Chevedden | 46.70% |
| Right To Act By Written Consent | Western Union Company (The) | John Chevedden | 27.20% |
| Right To Act By Written Consent | Honeywell International Inc. | John Chevedden | 31.90% |
| Right To Act By Written Consent | Assurant, Inc. | John Chevedden | 29.10% |
| Right To Act By Written Consent | Vertex Pharmaceuticals Incorporated | John Chevedden | 57.00% |
| Right To Act By Written Consent | ServiceNow, Inc. | John Chevedden | 36.50% |
| Right To Act By Written Consent | CBOE Holdings, Inc. | John Chevedden | 42.50% |
| Right To Act By Written Consent | Crown Holdings Inc. | John Chevedden | 42.60% |
| Right To Act By Written Consent | CMS Energy Corp. | John Chevedden | 36.00% |
| Right To Act By Written Consent | The Hartford Financial Services Group | John Chevedden | 45.00% |
| Right To Act By Written Consent | Annaly Capital Management | John Chevedden | 26.60% |
| Right To Act By Written Consent | McDonald’s Corp. | John Chevedden | 41.60% |
| Right To Act By Written Consent | MasterCard Incorporated | John Chevedden | 29.70% |
| Right To Act By Written Consent | DT Midstream, Inc. | John Chevedden | 30.10% |
| Right To Act By Written Consent | Global Payments Inc. | John Chevedden | 25.80% |
| Right To Act By Written Consent | IBM | John Chevedden | 37.30% |
| Right To Act By Written Consent | The Boeing Company | John Chevedden | 39.30% |
| Right To Act By Written Consent | Texas Instruments Inc. | John Chevedden | 44.60% |
| Right To Act By Written Consent | Cigna | John Chevedden | 47.80% |
| Right To Act By Written Consent | Synopsys, Inc. | John Chevedden | 40.00% |
| Right To Act By Written Consent | Deere & Company | John Chevedden | 38.30% |
| Right To Act By Written Consent | Jabil Circuit, Inc. | John Chevedden | 38.40% |
| Right To Act By Written Consent | Visa Inc. | John Chevedden | 32.80% |
| Right To Act By Written Consent | CVS Health Corp | John Chevedden | 40.20% |
| Right To Act By Written Consent | Verisk Analytics, Inc. | John Chevedden | 52.10% |
| Resolution | Company | Lead filer | Vote |
|---|---|---|---|
| Senior Executive Equity Retention | Edison International | John Chevedden | 37.40% |
| Resolution | Company | Lead filer | Vote |
|---|---|---|---|
| Separate Chair & CEO | Marvell Technology, Inc | John Chevedden | 36.00% |
| Separate Chair & CEO | Mondelez International, Inc. | John Chevedden | 31.20% |
| Separate Chair & CEO | Morgan Stanley | John Chevedden | 27.30% |
| Separate Chair & CEO | Home Depot Foundation | John Chevedden | 25.90% |
| Separate Chair & CEO | Ecolab Inc. | John Chevedden | 25.90% |
| Separate Chair & CEO | Dover Corporation | John Chevedden | 35.90% |
| Separate Chair & CEO | CDW Corp. | John Chevedden | 42.60% |
| Separate Chair & CEO | Lincoln National Corp. | John Chevedden | 28.60% |
| Separate Chair & CEO | Dana Holding Corporation | John Chevedden | 27.60% |
| Separate Chair & CEO | J.P. Morgan Chase & Co. | John Chevedden | 35.10% |
| Separate Chair & CEO | Quest Diagnostics | John Chevedden | 25.50% |
| Separate Chair & CEO | Corpay, Inc. | John Chevedden | 29.90% |
| Separate Chair & CEO | PPG Industries, Inc. | John Chevedden | 32.00% |
| Separate Chair & CEO | AMN Healthcare Services | John Chevedden | 25.10% |
| Separate Chair & CEO | Power Integrations, Inc. | John Chevedden | 45.20% |
| Separate Chair & CEO | Gilead Sciences, Inc. | John Chevedden | 27.10% |
| Separate Chair & CEO | Prudential Financial Inc. | John Chevedden | 30.50% |
| Separate Chair & CEO | Bristol-Myers Squibb Company | John Chevedden | 27.40% |
| Separate Chair & CEO | Avery Dennison Corporation | John Chevedden | 39.10% |
| Separate Chair & CEO | FirstEnergy Corporation | John Chevedden | 32.80% |
| Separate Chair & CEO | Lockheed Martin | John Chevedden | 35.20% |
| Separate Chair & CEO | Eversource Energy | John Chevedden | 26.50% |
| Separate Chair & CEO | Colgate Palmolive | John Chevedden | 28.60% |
| Separate Chair & CEO | West Pharmaceutical Services, Inc. | John Chevedden | 46.40% |
| Separate Chair & CEO | Pfizer Inc. | John Chevedden | 28.50% |
| Separate Chair & CEO | Huntsman Corporation | John Chevedden | 25.80% |
| Resolution | Company | Lead filer | Vote |
|---|---|---|---|
| Shareholder Vote on Poison Pill | Lumen Technologies (formerly CenturyLink) | John Chevedden | 47.80% |
Timothy Smith is Senior Policy Advisor at the Interfaith Center on Corporate Responsibility. Research assistance for this article was provided by Sehr Khaliq, ICCR Director of Evaluation.
Linkedin
BlueSky
Facebook
Mastodon
Substack
X (formerly Twitter)
I am pleased to report that we have reached our first agreement with a company…
This article proposes a new federal tax architecture grounded in Shared Capital — a model…
State treasurers and investor advocates mobilize to defend Rule 14a-8, which has allowed them to…
Over the coming months, my wife and I will ask several companies to conduct Board‑supervised…
Proxy Season: Governance Still Wins Proxy Season results for James McRitchie so far in spring…
Stretching Rule 14a-8. The SEC’s suspension of its decades-long Rule 14a-8 no-action process has created…